|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/17 | |
| A61K 38/18 | |||
| A61P 25/28 | |||
| A61P 27/06 | |||
| C12N 15/63 | |||
| C12N 15/861 |
| (11) | Patento numeris | 3606546 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18715911.6 |
| Europos patento paraiškos padavimo data | 2018-03-28 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-02-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-04-28 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/GB2018/050824 |
| Data | 2018-03-28 |
| (87) | Numeris | WO 2018/185468 |
| Data | 2018-10-11 |
| (30) | Numeris | Data | Šalis |
| 201705484 | 2017-04-05 | GB |
| (72) |
WIDDOWSON, Peter, GB
MARTIN, Keith, GB
|
| (73) |
Quethera Limited ,
300 Dashwood Lang Road
Bourne Business Park, Addlestone, KT15 2NX,
GB
|
| (54) | GENETIC CONSTRUCT FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISORDER OR STROKE |
| GENETIC CONSTRUCT FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISORDER OR STROKE |